Literature DB >> 28209659

Hyperlipidemia is a risk factor for osteonecrosis in children and young adults with acute lymphoblastic leukemia.

Signe Sloth Mogensen1, Kjeld Schmiegelow1,2, Kathrine Grell1,3, Birgitte Klug Albertsen4, Peder Skov Wehner5, Peter Kampmann6, Thomas Leth Frandsen7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28209659      PMCID： PMC5477618          DOI： 10.3324/haematol.2016.160507

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  13 in total

1.  Hypertriglyceridemia is associated with an elevated blood viscosity Rosenson: triglycerides and blood viscosity.

Authors:  Robert S Rosenson; Susan Shott; Christine C Tangney
Journal:  Atherosclerosis       Date:  2002-04       Impact factor: 5.162

2.  The toxicity of very prolonged courses of PEGasparaginase or Erwinia asparaginase in relation to asparaginase activity, with a special focus on dyslipidemia.

Authors:  Wing H Tong; Rob Pieters; Hester A de Groot-Kruseman; Wim C J Hop; Joachim Boos; Wim J E Tissing; Inge M van der Sluis
Journal:  Haematologica       Date:  2014-08-22       Impact factor: 9.941

3.  Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial.

Authors:  Leonard A Mattano; Meenakshi Devidas; James B Nachman; Harland N Sather; Stephen P Hunger; Peter G Steinherz; Paul S Gaynon; Nita L Seibel
Journal:  Lancet Oncol       Date:  2012-08-15       Impact factor: 41.316

4.  The effect of cortisone on femoral and humeral heads in rabbits. An experimental study.

Authors:  W L Jaffe; M Epstein; N Heyman; H J Mankin
Journal:  Clin Orthop Relat Res       Date:  1972 Jan-Feb       Impact factor: 4.176

Review 5.  Current concepts on the pathogenesis and natural history of steroid-induced osteonecrosis.

Authors:  Christian Powell; Christopher Chang; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2011-08       Impact factor: 8.667

6.  Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia.

Authors:  Jitesh D Kawedia; Sue C Kaste; Deqing Pei; John C Panetta; Xiangjun Cai; Cheng Cheng; Geoffrey Neale; Scott C Howard; William E Evans; Ching-Hon Pui; Mary V Relling
Journal:  Blood       Date:  2010-12-10       Impact factor: 22.113

7.  Complying with the European Clinical Trials directive while surviving the administrative pressure - an alternative approach to toxicity registration in a cancer trial.

Authors:  Thomas Leth Frandsen; Mats Heyman; Jonas Abrahamsson; Kim Vettenranta; Ann Åsberg; Goda Vaitkeviciene; Kaie Pruunsild; Nina Toft; Henrik Birgens; Helena Hallböök; Petter Quist-Paulsen; Laimonas Griškevičius; Louise Helt; Birgitte Vilsbøll Hansen; Kjeld Schmiegelow
Journal:  Eur J Cancer       Date:  2013-11-11       Impact factor: 9.162

8.  Asparaginase-associated pancreatitis in children with acute lymphoblastic leukaemia in the NOPHO ALL2008 protocol.

Authors:  Raheel A Raja; Kjeld Schmiegelow; Birgitte K Albertsen; Kaie Prunsild; Bernward Zeller; Goda Vaitkeviciene; Jonas Abrahamsson; Mats Heyman; Mervi Taskinen; Arja Harila-Saari; Jukka Kanerva; Thomas L Frandsen
Journal:  Br J Haematol       Date:  2014-01-15       Impact factor: 6.998

9.  Severe hypertriglyceridaemia during therapy for childhood acute lymphoblastic leukaemia.

Authors:  Deepa Bhojwani; Rashid Darbandi; Deqing Pei; Laura B Ramsey; Wassim Chemaitilly; John T Sandlund; Cheng Cheng; Ching-Hon Pui; Mary V Relling; Sima Jeha; Monika L Metzger
Journal:  Eur J Cancer       Date:  2014-07-30       Impact factor: 9.162

10.  Risk group assignment differs for children and adults 1-45 yr with acute lymphoblastic leukemia treated by the NOPHO ALL-2008 protocol.

Authors:  Nina Toft; Henrik Birgens; Jonas Abrahamsson; Per Bernell; Laimonas Griškevičius; Helene Hallböök; Mats Heyman; Mette Skov Holm; Erik Hulegårdh; Tobias Wirenfeldt Klausen; Hanne V Marquart; Olafur Gísli Jónsson; Ove Juul Nielsen; Petter Quist-Paulsen; Mervi Taskinen; Goda Vaitkeviciene; Kim Vettenranta; Ann Åsberg; Kjeld Schmiegelow
Journal:  Eur J Haematol       Date:  2013-04-02       Impact factor: 2.997
View more
  19 in total

1.  Asparaginase formulation impacts hypertriglyceridemia during therapy for acute lymphoblastic leukemia.

Authors:  Emily R Finch; Colton A Smith; Wenjian Yang; Yiwei Liu; Nancy M Kornegay; John C Panetta; Kristine R Crews; Alejandro R Molinelli; Cheng Cheng; Deqing Pei; Laura B Ramsey; Seth E Karol; Hiroto Inaba; John T Sandlund; Monika Metzger; William E Evans; Sima Jeha; Ching-Hon Pui; Mary V Relling
Journal:  Pediatr Blood Cancer       Date:  2019-10-14       Impact factor: 3.167

Review 2.  Osteonecrosis in children and adolescents with acute lymphoblastic leukemia: a therapeutic challenge.

Authors:  Michaela Kuhlen; Marina Kunstreich; Kathinka Krull; Roland Meisel; Arndt Borkhardt
Journal:  Blood Adv       Date:  2017-06-13

Review 3.  [Osteonecrosis-severe side effect of treatment for acute lymphoblastic leukemia].

Authors:  Michaela Kuhlen; Marina Kunstreich; Nicola Gökbuget; Gabriele Escherich
Journal:  Orthopadie (Heidelb)       Date:  2022-09-07

Review 4.  Polysaccharides from Medicine and Food Homology Materials: A Review on Their Extraction, Purification, Structure, and Biological Activities.

Authors:  Jiaqi Xu; Jinling Zhang; Yumei Sang; Yaning Wei; Xingyue Chen; Yuanxin Wang; Hongkun Xue
Journal:  Molecules       Date:  2022-05-17       Impact factor: 4.927

Review 5.  The Role of MicroRNAs in Hyperlipidemia: From Pathogenesis to Therapeutical Application.

Authors:  Yu Xiang; Li Mao; Mei-Ling Zuo; Gui-Lin Song; Li-Ming Tan; Zhong-Bao Yang
Journal:  Mediators Inflamm       Date:  2022-06-17       Impact factor: 4.529

6.  Engineered three-dimensional scaffolds for enhanced bone regeneration in osteonecrosis.

Authors:  Tongtong Zhu; Yutao Cui; Mingran Zhang; Duoyi Zhao; Guangyao Liu; Jianxun Ding
Journal:  Bioact Mater       Date:  2020-04-17

7.  British OsteoNEcrosis Study (BONES) protocol: a prospective cohort study to examine the natural history of osteonecrosis in older children, teenagers and young adults with acute lymphoblastic leukaemia and lymphoblastic lymphoma.

Authors:  Nadia Amin; Sally Kinsey; Richard Feltbower; Jeannette Kraft; Elizabeth Whitehead; Mark Velangi; Beki James
Journal:  BMJ Open       Date:  2019-05-22       Impact factor: 2.692

8.  Maintenance therapy and risk of osteonecrosis in children and young adults with acute lymphoblastic leukemia: a NOPHO ALL2008 sub-study.

Authors:  Linea Natalie Toksvang; Liv Andrés-Jensen; Cecilie Utke Rank; Riitta Niinimäki; Jacob Nersting; Stine Nygaard Nielsen; Signe Sloth Mogensen; Arja Harila-Saari; Jonas Abrahamsson; Joel Joelsson; Ulrik Malthe Overgaard; Petter Quist-Paulsen; Laimonas Griškevičius; Ólafur Gisli Jónsson; Goda Vaitkevičienė; Thomas Leth Frandsen; Nina Toft; Kathrine Grell; Kjeld Schmiegelow
Journal:  Cancer Chemother Pharmacol       Date:  2021-06-18       Impact factor: 3.333

Review 9.  Recent perspectives on the association between osteonecrosis and bone mineral density decline in childhood acute lymphoblastic leukemia.

Authors:  Jenneke E van Atteveld; Demi Tc de Winter; Rob Pieters; Sebastian Jcmm Neggers; Marry M van den Heuvel-Eibrink
Journal:  Fac Rev       Date:  2021-06-23

10.  Anti-hyperlipidemic effects of the compound Danshen tablet: roles of antioxidation, anti-inflammation, anticoagulation, and anti-apoptosis.

Authors:  Haibiao Guo; Lin Chen; Chuyuan Li; Deqin Wang; Yun Luo; Guibo Sun; Xiaobo Sun
Journal:  Ann Transl Med       Date:  2021-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.